UiPath stock faces support test: Technical outlook

Traders Union
All News
Stocks
UiPath slides 7.5% today to $14.07

Highlights

UiPath reported fiscal Q2 2027 revenue of $410.26 million, up 13% year over year, with adjusted EPS at $0.15.
Management projected a more cautious growth outlook and billings came in lower than expected, prompting investor focus on upcoming strategic updates.
Shares of UiPath dropped sharply to $14.07, with technical signals indicating strong downside momentum and a trading range of $12.28 to $15.86 likely over the next few days.

Muted outlook and soft billings temper revenue beat impact

UiPath's fiscal Q2 2027 results, reported on September 4, 2026, showed a 13% year-over-year revenue increase to $410.26 million, adjusted EPS of $0.15, and a 12% climb in annual recurring revenue to $1.938 billion, according to Blockonomi. However, while revenue figures exceeded consensus estimates, a more cautious growth outlook and lower-than-expected billings signaled concerns around sustained expansion, weighing on market sentiment. Looking ahead, investor attention is focused on UiPath’s upcoming investor day scheduled for September 22, 2026, when management is expected to address acceleration strategies in response to current performance trends.

Bearish momentum intensifies as oversold signals dominate

PATH is trading below the 20- and 50-period moving averages, with the 200-period average providing relative support to the downside. The Ichimoku Kijun at $16.8 marks immediate resistance, while price is sitting near session lows. Momentum indicators confirm pronounced weakness: MACD and ADX are both showing sell signals, and the RSI stands at an extremely oversold 22.19. Oversold readings from CCI and Stoch RSI, as well as a strongly negative Bull/Bear Power reading, underline the dominance of sellers. Awesome Oscillator direction offers no strong support, and intraday momentum remains consistently negative without signal divergence.

Rangebound action seen as downside risk outweighs reversal odds

Over the next 2–3 trading days, PATH is expected to consolidate within a range capped by resistance at $15.86 and with lower support near $12.28, based on typical volatility. The baseline scenario is continued trading within this band, while a move below $12.28 could see further selling accelerate. Any reversal higher would require a clear breakout above the $16.8 resistance, a scenario currently rated as very low probability.

Anton Kharitonov, analyst at Traders Union, sees PATH under clear pressure following muted Q2 guidance and a decisive momentum breakdown. He notes that technical signals are uniformly negative, with oversold readings aligning to bearish sentiment on management’s softer outlook. The analyst believes a move below $12.28 could trigger further selling, while meaningful recovery is unlikely unless resistance at $16.8 is reclaimed. "Until price stabilizes above core resistance, I remain defensive and see no high-conviction long setup here."

Earlier, analysts noted that persistent selling pressure and mixed technical signals had increased downside risk for UiPath, reinforcing a cautious outlook. Current price action and momentum readings now strengthen this view, with the key level to watch being support near $12.28 should further weakness unfold.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.